The global launch strategy and market access consultancy working exclusively with novel products designed to help those living with rare disorders

A new consultancy with tried and trusted methodology, led by a senior team with over 50 years' experience, working on more than 50 successful products launches at national, regional and global level.

Craig Dixon
Principal Consultant - Strategy

Craig’s expertise in life sciences strategy has been gained from over twenty years working with leading pharmaceutical companies both as an industry employee and as a consultant.

During his time in industry, Craig led teams launching novel products. Responsible for strategy and ensuring aligned tactical implementation, Craig has been instrumental in driving orphan drugs to achieve blockbuster status. As a consultant, Craig has been called upon to develop launch strategies for orphan and biological brands at a global and country level by some of the world’s leading rare disorder companies.

Craig has been working with novel products for rare disorders for over fifteen years across multiple therapeutic areas.

Andrew Mumford
Principal Consultant - Market Access

Andrew is an experienced pharmaceutical and healthcare global Market Access expert. Having gained initial experience in field based and market access commercial roles, his career moved into senior management roles leading HTA submissions, pricing and reimbursement projects, Value Dossier development, and Value Communication across global markets.

Andrew has a unique set of experience, developing and implementing access initiatives with a particular focus on launching new products in the rare disorder arena. His focus is primarily to ensure clinical demand, value demonstration and acceptance by the payer customer group independent of their market, data set and belief.

Joanne Mumford
Principal Consultant - Strategic Insights

Joanne is an experienced strategist whose core strengths lie in uncovering true insight to drive business decisions and inform strategic directions.

Her career has encompassed market research, marketing and senior management roles where she has developed a wide network of payers and clinician contacts throughout global markets. This broad range of industry experience provides Joanne a panoramic view of markets and opportunities.

Craig Dixon
Principal Consultant - Strategy

Craig’s expertise in life sciences strategy has been gained from over twenty years working with leading pharmaceutical companies both as an industry employee and as a consultant.

During his time in industry, Craig led teams launching novel products. Responsible for strategy and ensuring aligned tactical implementation, Craig has been instrumental in driving orphan drugs to achieve blockbuster status. As a consultant, Craig has been called upon to develop launch strategies for orphan and biological brands at a global and country level by some of the world’s leading rare disorder companies.

Craig has been working with novel products for rare disorders for over fifteen years across multiple therapeutic areas.

Andrew Mumford
Principal Consultant - Market Access

Andrew is an experienced pharmaceutical and healthcare global Market Access expert. Having gained initial experience in field based and market access commercial roles, his career moved into senior management roles leading HTA submissions, pricing and reimbursement projects, Value Dossier development, and Value Communication across global markets.

Andrew has a unique set of experience, developing and implementing access initiatives with a particular focus on launching new products in the rare disorder arena. His focus is primarily to ensure clinical demand, value demonstration and acceptance by the payer customer group independent of their market, data set and belief.

Joanne Mumford
Principal Consultant - Strategic Insights

Joanne is an experienced strategist whose core strengths lie in uncovering true insight to drive business decisions and inform strategic directions.

Her career has encompassed market research, marketing and senior management roles where she has developed a wide network of payers and clinician contacts throughout global markets. This broad range of industry experience provides Joanne a panoramic view of markets and opportunities.

Working closely with Andrew, Craig and Joanne are a wider team of Consultants, Associates and Analysts specialising in Health Economics, Medico-Marketing, Government Affairs, Payer Research and Value Demonstration

Services

Every client and product is unique so Initiate will always provide bespoke services to fulfil the requirements, which may include:

Positioning &
launch strategy
Cross matrix strategy
development
Launch planning
Launch readiness
review process
Payer insight
Pre-launch pricing strategy
Value proposition development
& global value dossier
Value demonstration
HTA's & pricing and
reimbursement submissions
Tender strategy
platform

Initiate's offering is further strengthened through its close relationship with emotive, a global healthcare communications agency specialising in novel therapies, including those for rare disorders.